Navigation Links
Bionovo Announces 2009 Highlights and Year-End Financial Results
Date:3/15/2010

ntial pharmacological uses. In addition, our studies have indicated that these compounds do not promote breast or endometrial cancer in animal models, unlike estrogen therapies. This suggests that these ER beta-selective compounds could lead to safer, more appealing therapies for menopausal disorders.
  • Publication of final study results from our Phase 1B trial of Bezielle for metastatic breast cancer. Bezielle showed an excellent safety and tolerability profile. It also showed promising early efficacy in a difficult-to-treat population, including stable disease and tumor regression.
  • International presentation of final study results from our Phase 2 trial of Menerba for menopausal vasomotor symptom treatment. These results included:
    • After 12 weeks of treatment, there was a statistically significant decrease in frequency of all hot flashes in the higher dose of Menerba (p=0.04).
    • There was a clear dose response trend in multiple efficacy analyses.
    • Menerba reduced the number of times women were awakened from sleep due to hot flashes (night sweats). The median percent reduction in night sweats in the higher dose of Menerba was 67%, statistically superior to placebo (p=0.05).
    • Compliance and study retention was excellent: 98% of participants completed the trial, with 91% of participants taking at least 75% of the assigned study medication.
    • The only statistically significant adverse event was "transient loose stools" (12% on Menerba vs. 3% on placebo).
    • During the trial, there was no difference in the number of uterine bleeding episodes between the treatment g
      '/>"/>

    SOURCE Bionovo, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

    Related medicine technology :

    1. Bionovo, Inc. to Announce Fourth Quarter and Fiscal Year 2009 Financial Results on Monday, March 15, 2010
    2. Bionovo Announces Publication of Positive Results From the Phase 1B Clinical Trial of Bezielle (BZL101) for Metastatic Breast Cancer
    3. Bionovo Announces Third Quarter 2009 Highlights and Financial Results
    4. Bionovo, Inc. to Announce Third Quarter Fiscal Year 2009 Financial Results on Thursday, November 5, 2009
    5. Bionovo Announces Publication of Data on Potential Increase in Breast Cancer Risk Due to the Inhibitory Effect of Tamoxifen Treatment on Estrogen Receptor Beta
    6. Bionovo Announces Second Quarter 2009 Highlights and Financial Results
    7. Bionovos Estrogen Receptor Beta Selective Drugs Have Unique Gene Expression and Cell Type Specificity
    8. Bionovo Announces First Quarter 2009 Highlights and Financial Results
    9. Bionovo Announces Development Plans for Menopausal Hot Flash Drug Candidate, Menerba (MF101), Following FDA Meetings
    10. Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology
    11. Bionovo Advances BZL101 to Phase 2 Clinical Trials After Positive Phase 1 Results for Metastatic Breast Cancer
  • Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:11/28/2014)...  (Booth #7309, North Hall) — Dicom Systems ... DCMSYS Interface WebBridge, at the 100th annual RSNA Meeting ... Chicago, Illinois . ... for medical facilities of any size, WebBridge allows any ... non-standard data (e.g. JPEG, TFF, PDF, TXT, etc.) to ...
    (Date:11/27/2014)... 2014 Hovione announced today it ... with the U.S. Food and Drug Administration (FDA). This ... improved drug delivery options for established drugs. ... formulation using a new patented crystalline base form of ... prescribed oral antibiotics for acne. Currently, there are no ...
    (Date:11/26/2014)... 26, 2014  Perrigo Company plc ("Perrigo") (NYSE: ... "Quality Affordable Healthcare Products®," today announced the closing of ... sale of 6,809,210 ordinary shares at a public offering ... of the option to purchase up to an additional ... Barclays Capital Inc., as representatives of the several underwriters. ...
    Breaking Medicine Technology:Dicom Systems Announces WebBridge Interface at RSNA 2014 2Hovione Files its First Investigational New Drug Application With the FDA 2Perrigo Company plc Announces The Closing Of Its Registered Public Offering Of Ordinary Shares 2Perrigo Company plc Announces The Closing Of Its Registered Public Offering Of Ordinary Shares 3Perrigo Company plc Announces The Closing Of Its Registered Public Offering Of Ordinary Shares 4
    ... the Potential Utility of Modigene,s CTP Technology ... ... Va., Sept. 24 Modigene Inc. (OTC,Bulletin Board: MODG) today reported ... journal Endocrinology showing that,erythropoietin (EPO) linked to Modigene,s carboxyl terminal peptide ...
    ... 24 Iodine has been used as an,antimicrobial ... about molecular,iodine yet many women suffering from Fibrocystic ... may soon yield an effective,nonhormonal treatment. While ... market, all,available hormonal therapies have significant adverse events. ...
    Cached Medicine Technology:Study Published in Endocrinology Reports Potential of Modigene Technology to Extend Duration of Protein Drugs 2Study Published in Endocrinology Reports Potential of Modigene Technology to Extend Duration of Protein Drugs 3Study Published in Endocrinology Reports Potential of Modigene Technology to Extend Duration of Protein Drugs 4Symbollon Pharmaceuticals, Inc. Evaluates the Clinical Effects of IoGen(TM) on Fibrocystic Breast Disease 2
    (Date:11/28/2014)... Novatus, a leading provider of ... which provides customers with greater reporting capabilities, more ... “As we continue to evolve and grow the ... and improved performance in response to requests from ... “With the enhancements that we have made to ...
    (Date:11/28/2014)... Miami's Plastic Surgery of the Face recently ... Dr. Jeffrey Epstein is excited to offer patients ... platform, the site is uniquely designed for easing viewing ... 75% of all prospective rhinoplasty patients research upcoming procedures ... on with smartphones, tablets, and laptops, as well as ...
    (Date:11/28/2014)... Celebration can quickly turn to tragedy if popular turkey ... Over the last decade, more than 141 serious fires ... turkey fryers, according to the U.S. Consumer Product Safety ... who tried to deep fry the turkey indoors, which ... Arthur Sanford, a burn surgeon at Loyola University Health ...
    (Date:11/28/2014)... PA (PRWEB) November 28, 2014 An inventor ... curing light on a patient’s filling and it was almost ... more ergonomic curing light," she said. , The patent-pending Access ... It eases access to areas of the mouth, as well ... promotes efficiency and safety. Easy to use and clean, it ...
    (Date:11/28/2014)... 2014 UniWigs.com, a leader in the wig industry, ... to the next Monday. This promotion features: , ... items up to 70% off (no coupon code needed), ... Free shipping on orders over $49 , Visit http://www.uniwigs.com ... from Nov. 28th to Dec. 1st and the first 100 shoppers ...
    Breaking Medicine News(10 mins):Health News:Novatus Releases v5.1 with New Advanced Reporting Capabilities 2Health News:Top Rhinoplasty Surgeon Launches Innovative Website 2Health News:Turkey Fryer Mishaps Can Cause Serious Burns 2Health News:Pre-X'mas Crazy Sale Starts from $0 at UniWigs.com 2
    ... cancer surgeons regularly confer with plastic surgeons prior to surgery, ... a new study led by researchers at the University of ... breast cancer treatment can vary widely ranging from small ... the type of care a woman receives when it comes ...
    ... ,PHOENIX, Ariz. Aug. 31, 2010 The first study ... how they affect cell growth has identified two potential anti-cancer ... Genomics Research Institute (TGen) published this month in the journal ... aggressive cancer lesions that occur most frequently in the bones ...
    ... exposed to violence in their community are at an increased ... asthma or any cause, according to new research from the ... violence has been linked to more symptoms in pediatric asthma ... a longitudinal study showing a connection in an adult population ...
    ... cancer deaths worldwide, and the prognosis is generally poor, ... one type of lung cancer, adenocarcinoma, has been increasing ... in tumor cell biology that result in a more ... tissue) that have been completely surgically removed may help ...
    ... Portugal: Hundreds of millions of euros are being ... consulting community pharmacists rather than going straight to their ... 1 September) at the annual conference of the International ... million was freed up in one year for other ...
    ... Selenium effects may vary according to individual,s characteristics. ... cancer. According to results of a study published ... Prevention , a journal of the American Association for Cancer ... cancer. "The lower the levels of selenium, the ...
    Cached Medicine News:Health News:Surgeons impact whether a woman gets breast reconstruction, U-M study finds 2Health News:TGen finds therapeutic targets for rare cancer in children 2Health News:Violence in inner city neighborhoods contributes to trouble with asthma 2Health News:Tumor budding identified as predictor for unfavorable outcome in lung cancer 2Health News:Health advice from pharmacists saves hundreds of millions of euros 2Health News:Health advice from pharmacists saves hundreds of millions of euros 3Health News:Increasing selenium intake may decrease bladder cancer risk 2
    The new BioZ Dx incorporates the world's most advanced impedance cardiography (ICG) technology and powerful reporting features to quickly and easily provide noninvasive hemodynamic parameters....
    ... Implant is an endoscopic urethral implant ... (SUI). Upon implantation, the Tegress™ Implant ... (EVOH) in a Dimethyl Sulfoxide (DMSO) ... that reinforces the integrity of the ...
    ... reproducible re-entry of a guidewire from the ... of a peripheral vessel., , Locate ... facilitates rapid and accurate orientation of the ... eliminates the need for additional equipment, , ...
    ... system is intended for the qualitative detection ... When performed according to these instructions, the ... clinical information, may aid in the determination ... diagnosis of VZV infections. This test is ...
    Medicine Products: